Last reviewed · How we verify
Dabigatran Etexilate 150mg
Dabigatran Etexilate 150mg is a Small molecule drug developed by Kafrelsheikh University. It is currently FDA-approved. Also known as: group A.
At a glance
| Generic name | Dabigatran Etexilate 150mg |
|---|---|
| Also known as | group A |
| Sponsor | Kafrelsheikh University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus (PHASE3)
- Dabigatran for Mitral Stenosis Atrial Fibrillation (PHASE4)
- Bioequivalence Study of Two Dabigatran Etexilate Mesylate Capsules in Healthy Subjects (PHASE1)
- Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study). (PHASE4)
- A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age. (PHASE1)
- Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation (EARLY_PHASE1)
- Prospective Comparison of Incidence of Heavy Menstrual Bleeding in Women Treated With Direct Oral Anticoagulants
- Dabigatran Versus Rivaroxaban in Cerebral Venous Thrombosis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dabigatran Etexilate 150mg CI brief — competitive landscape report
- Dabigatran Etexilate 150mg updates RSS · CI watch RSS
- Kafrelsheikh University portfolio CI
Frequently asked questions about Dabigatran Etexilate 150mg
What is Dabigatran Etexilate 150mg?
Dabigatran Etexilate 150mg is a Small molecule drug developed by Kafrelsheikh University.
Who makes Dabigatran Etexilate 150mg?
Dabigatran Etexilate 150mg is developed and marketed by Kafrelsheikh University (see full Kafrelsheikh University pipeline at /company/kafrelsheikh-university).
Is Dabigatran Etexilate 150mg also known as anything else?
Dabigatran Etexilate 150mg is also known as group A.
What development phase is Dabigatran Etexilate 150mg in?
Dabigatran Etexilate 150mg is FDA-approved (marketed).
Related
- Manufacturer: Kafrelsheikh University — full pipeline
- Also known as: group A
- Compare: Dabigatran Etexilate 150mg vs similar drugs
- Pricing: Dabigatran Etexilate 150mg cost, discount & access